Patrick Burnett Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Patrick Burnett is Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 128,669 shares of ARQT, which is worth approximately $1.48 Million. The most recent transaction as insider was on Nov 22, 2024, when has been sold 16,023 shares (Common Stock) at a price of $10.14 per share, resulting in proceeds of $162,473. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K
33.97% 3M change
120.49% 12M change
Total Value Held $1.48 Million

Patrick Burnett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2024
SELL
Open market or private sale
$162,473 $10.14 p/Share
16,023 Reduced 11.07%
128,669 Common Stock
Nov 22 2024
BUY
Exercise of conversion of derivative security
-
16,023 Added 9.97%
144,692 Common Stock
Nov 15 2024
SELL
Open market or private sale
$1,002 $10.03 p/Share
100 Reduced 0.08%
128,669 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
-
100 Added 0.08%
128,769 Common Stock
Nov 14 2024
SELL
Open market or private sale
$711,306 $10.29 p/Share
69,126 Reduced 34.95%
128,669 Common Stock
Nov 14 2024
BUY
Exercise of conversion of derivative security
-
18,377 Added 11.11%
147,046 Common Stock
Nov 04 2024
SELL
Open market or private sale
$134,027 $8.68 p/Share
15,441 Reduced 7.92%
179,418 Common Stock
Aug 19 2024
SELL
Open market or private sale
$14,325 $8.29 p/Share
1,728 Reduced 0.88%
194,859 Common Stock
Aug 02 2024
SELL
Open market or private sale
$119,118 $9.02 p/Share
13,206 Reduced 6.29%
196,587 Common Stock
May 30 2024
SELL
Open market or private sale
$201,250 $8.75 p/Share
23,000 Reduced 9.88%
209,793 Common Stock
May 30 2024
BUY
Exercise of conversion of derivative security
-
23,000 Added 8.99%
232,793 Common Stock
May 29 2024
SELL
Open market or private sale
$435,581 $8.72 p/Share
49,952 Reduced 19.23%
209,793 Common Stock
May 02 2024
SELL
Open market or private sale
$83,510 $8.74 p/Share
9,555 Reduced 3.55%
259,745 Common Stock
Mar 04 2024
SELL
Open market or private sale
$53,175 $11.12 p/Share
4,782 Reduced 1.74%
269,300 Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
189,050 Added 40.82%
274,082 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
28,000 Added 24.77%
85,032 Common Stock
Jan 02 2024
SELL
Open market or private sale
$4,690 $3.54 p/Share
1,325 Reduced 2.27%
57,032 Common Stock
Aug 21 2023
SELL
Open market or private sale
$11,315 $7.05 p/Share
1,605 Reduced 2.68%
58,357 Common Stock
Mar 06 2023
SELL
Open market or private sale
$12,986 $15.26 p/Share
851 Reduced 1.4%
59,962 Common Stock
Mar 02 2023
SELL
Open market or private sale
$28,313 $16.17 p/Share
1,751 Reduced 4.21%
39,813 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
21,000 Added 25.67%
60,813 Common Stock
Jan 03 2023
SELL
Open market or private sale
$22,139 $15.01 p/Share
1,475 Reduced 3.43%
41,564 Common Stock
Mar 07 2022
SELL
Open market or private sale
$493 $16.44 p/Share
30 Reduced 0.07%
43,039 Common Stock
Mar 04 2022
SELL
Open market or private sale
$16,540 $16.86 p/Share
981 Reduced 2.23%
43,069 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
17,800 Added 28.78%
44,050 Common Stock
PB

Patrick Burnett

Officer
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT